190 related articles for article (PubMed ID: 38217680)
1. IBD-PODCAST Spain: A Close Look at Current Daily Clinical Practice in IBD Management.
Vega P; Huguet JM; Gómez E; Rubio S; Suarez P; Vera MI; Paredes JM; Hernández-Camba A; Plaza R; Mañosa M; Pajares R; Sicilia B; Madero L; Kolterer S; Leitner C; Heatta-Speicher T; Michelena N; Santos de Lamadrid R; Dignass A; Gomollón F
Dig Dis Sci; 2024 Mar; 69(3):749-765. PubMed ID: 38217680
[TBL] [Abstract][Full Text] [Related]
2. Effect of Suboptimal Disease Control on Patient Quality of Life: Real-World Data from the Observational IBD-PODCAST Canada Trial.
Siffledeen J; Singh S; Shulman SM; Igoe J; Heatta-Speicher T; Leitner C; Chung CH; Targownik L
Dig Dis Sci; 2024 May; 69(5):1636-1648. PubMed ID: 38493273
[TBL] [Abstract][Full Text] [Related]
3. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
[TBL] [Abstract][Full Text] [Related]
4. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn's disease) in Spain: A Systematic Review.
Barreiro-de Acosta M; Molero A; Artime E; Díaz-Cerezo S; Lizán L; de Paz HD; Martín-Arranz MD
Adv Ther; 2023 May; 40(5):1975-2014. PubMed ID: 36928496
[TBL] [Abstract][Full Text] [Related]
5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
Burisch J
Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
[TBL] [Abstract][Full Text] [Related]
6. Medical Management of Inflammatory Bowel Disease.
Rahman S; Patel RK; Boden E; Tsikitis VL
Surg Clin North Am; 2024 Jun; 104(3):657-671. PubMed ID: 38677828
[TBL] [Abstract][Full Text] [Related]
7. Pathobionts in Inflammatory Bowel Disease: Origins, Underlying Mechanisms, and Implications for Clinical Care.
Gilliland A; Chan JJ; De Wolfe TJ; Yang H; Vallance BA
Gastroenterology; 2024 Jan; 166(1):44-58. PubMed ID: 37734419
[TBL] [Abstract][Full Text] [Related]
8. The impact of symptom severity on the humanistic and economic burden of inflammatory bowel disease: a real-world data linkage study.
Naegeli AN; Balkaran BL; Shan M; Hunter TM; Lee LK; Jairath V
Curr Med Res Opin; 2022 Apr; 38(4):541-551. PubMed ID: 35175166
[TBL] [Abstract][Full Text] [Related]
9. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
11. The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease-A Real-World Study.
Lewis JD; Gibble TH; Shan M; Zhou X; Naegeli AN; Dawwas GK
Drugs Real World Outcomes; 2024 Jun; ():. PubMed ID: 38878264
[TBL] [Abstract][Full Text] [Related]
12. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
[TBL] [Abstract][Full Text] [Related]
13. Work-Related Productivity Loss and Associated Indirect Costs in Patients With Crohn's Disease or Ulcerative Colitis in the United States.
Ding Z; Muser E; Izanec J; Lukanova R; Kershaw J; Roughley A
Crohns Colitis 360; 2022 Jul; 4(3):otac023. PubMed ID: 36777416
[TBL] [Abstract][Full Text] [Related]
14. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
15. Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics.
Mandel MD; Bálint A; Lovász BD; Gulácsi L; Strbák B; Golovics PA; Farkas K; Kürti Z; Szilágyi BK; Mohás A; Molnár T; Lakatos PL
Eur J Health Econ; 2014 May; 15 Suppl 1():S121-8. PubMed ID: 24832845
[TBL] [Abstract][Full Text] [Related]
16. P043 Resource Utilization and Productivity Loss among Patients with Inflammatory Bowel Disease in Sweden: A Longitudinal Nationwide Population-based Study.
Cai Q; Sanon M; Batyrbekova N; Di Scala L; Kavanagh S
Am J Gastroenterol; 2021 Dec; 116(Suppl 1):S11. PubMed ID: 37461961
[TBL] [Abstract][Full Text] [Related]
17. Rate of Adverse Events and Associated Health Care Costs for the Management of Inflammatory Bowel Disease in Germany.
Wilke T; Groth A; Long GH; Tatro AR; Sun D
Clin Ther; 2020 Jan; 42(1):130-143.e3. PubMed ID: 31883702
[TBL] [Abstract][Full Text] [Related]
18. Real-world treatment patterns and disease control over one year in patients with inflammatory bowel disease in Brazil.
Sassaki LY; Miszputen SJ; Kaiser Junior RL; Catapani WR; Bafutto M; Scotton AS; Zaltman C; Baima JP; Ramos HS; Faria MAG; Gonçalves CD; Guimaraes IM; Flores C; Amarante HMBS; Nones RB; Parente JML; Lima MM; Chebli JM; Ferrari MLA; Campos JF; Sanna MGP; Ramos O; Parra RS; da Rocha JJR; Feres O; Feitosa MR; Caratin RF; Senra JT; Santana GO
World J Gastroenterol; 2021 Jun; 27(23):3396-3412. PubMed ID: 34163120
[TBL] [Abstract][Full Text] [Related]
19. Interventions for the management of abdominal pain in Crohn's disease and inflammatory bowel disease.
Sinopoulou V; Gordon M; Akobeng AK; Gasparetto M; Sammaan M; Vasiliou J; Dovey TM
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD013531. PubMed ID: 34844288
[TBL] [Abstract][Full Text] [Related]
20. Indicators of active disease and steroid dependency in patients with inflammatory bowel diseases not treated with biologics in a German real-world-setting.
Bokemeyer B; Ghiani M; Fuchs A; Deiters B; Hardtstock F; Brandes A; Knop J; Orzechowski HD; Wilke T
Int J Colorectal Dis; 2020 Aug; 35(8):1587-1598. PubMed ID: 32424526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
